Efficacy of a Novel Red light with Micro-needling Patch for Facial Skin Texture
- Conditions
- patients with facial wrinklewrinkle, Skin rejuvenation
- Registration Number
- TCTR20240722008
- Lead Sponsor
- Bangkok Dusit Medical Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
1.Participants female and male with age 25 to 55 years old with modified Fitzpatrick Wrinkle Scale more than class 1
2.Pre-menopause female
1.Menopause
2.Current tobacco use
3.Tattoos that cover the proposed skin surface
4.Outdoor workers and sun exposure risk
5.Any skin lesions that might affect the study results such as atopic dermatitis ,herpes simplex infection, history of active or systemic infection, history of hypertrophic scar, eczema or sunburn in the area
6.Any history of adverse effects of polymethylmethacrylate (PMMA)
7.Have done Neuromodulators treatment (Botulinum toxins injections) within 6 months
8.Have done Filler injections in the nasolabial fold and periorbital within 1 year
9.Use of energy-based devices within 1 year
10.Have done Mesotherapy injections within 1 month
11.Have done Biostimulator injection within 6 months
12.Have done any sort of energy-based device within 1 year
13.Have done any sort of LASERs or skin resurface procedures within 1 months
14.Underlying with Photosensitivity condition including Porphyria, Lupus erythematosus, Rosacea, Solar urticaria
15.Underlying with bleeding diseases
16.Currently on Vitamin A derivatives, anticoagulants
17.Pregnant or on Lactation
18.Daily use anti-wrinkles facial cream and/or lotion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.